On this page:OverviewKey papers
ScholarIQanswers from OpenAlex

Targeted Oncology

JournalCitation impact & published research

Targeted Oncology is a journal indexed in ScholarIQ from OpenAlex.

How many works does Targeted Oncology have?

ScholarIQindexed works

Targeted Oncology has 1,231 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Targeted Oncology have?

ScholarIQcitation count

Targeted Oncology has 27,143 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Targeted Oncology?

ScholarIQh-index

Targeted Oncology has an h-index of 73 in OpenAlex.

What is the article processing charge of Targeted Oncology?

ScholarIQarticle processing charge

Targeted Oncology lists an article processing charge of 4,390 USD in OpenAlex.

What is the OpenAlex record for Targeted Oncology?

ScholarIQopenalex

The OpenAlex for Targeted Oncology is on the source record.

What are the most-cited papers on Targeted Oncology?

ScholarIQmost cited works
Renal Toxicities of Targeted Therapies
Anum Abbas, Mohsin Mirza, Apar Kishor Ganti, Ketki Tendulkar
Targeted Oncology. 201592 Citations
Immune Checkpoint Inhibitor-Induced Colitis: Diagnosis and Management
Caroline Prieux‐Klotz, Marie Dior, Diane Damotte, Johann Dréanic, Bertrand Brieau, Catherine Brézault, Véred Abitbol, Stanislas Chaussade, Romain Coriat
Targeted Oncology. 201776 Citations
Comparison of acute toxicity and mortality after two different dosing regimens of high-dose interleukin-2 for patients with metastatic melanoma
Laura Alwan, Kenneth F. Grossmann, Daniel S. Sageser, Joan Van Atta, Neeraj Agarwal, Jeffrey A. Gilreath
Targeted Oncology. 201356 Citations
TRK Fusion Cancer: Patient Characteristics and Survival Analysis in the Real-World Setting
Lyudmila Bazhenova, Andrew Lokker, Jeremy Snider, Emily Castellanos, Virginia Fisher, Marc Fellous, Shivani Nanda, Jihong Zong, Karen Keating, Xiaolong Jiao
Targeted Oncology. 202145 CitationsOPEN ACCESS
Clinical Modality of Resistance and Subsequent Management of Patients with Advanced Non-small Cell Lung Cancer Failing Treatment with Osimertinib
Yuxin Mu, Xuezhi Hao, Ke Yang, Di Ma, Shouzheng Wang, Ziyi Xu, Junling Li, Puyuan Xing
Targeted Oncology. 201940 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · 14-day free trial